Ghost Tree Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Ghost Tree Capital’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-176,513	Closed	-$2.78M	–	85
2024 Q1	$2.78M	Sell	176,513 -48,487	-22%	-$746K	0.77%	42
2023 Q4	$3.63M	Sell	225,000 -100,000	-31%	-$1.28M	1.19%	26
2023 Q3	$4.13M	Buy	+325,000	New	+$4.48M	1.36%	27
2017 Q4	–	Sell	-64,410	Closed	-$1.22M	–	72
2017 Q3	$1.22M	Buy	+64,410	New	+$1.18M	0.26%	59

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Ghost Tree Capital's DCPH Position: Q2 2024 in Review

Ghost Tree Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 176,513 shares — an estimated $2.78M sold.

Ghost Tree Capital first reported a position in DCPH in Q3 2017 and held it in 4 quarters. The position peaked at $4.13M in Q3 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Ghost Tree Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Ghost Tree Capital sold 176,513 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.78M.
Ghost Tree Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
Ghost Tree Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.13M in Q3 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Ghost Tree Capital's 13F filing for Q2 2024, filed 14 Aug 2024.